Cedrol mitigates atherosclerosis by inhibiting foam cell formation and inflammatory response via suppression of NOD-like receptor family pyrin domain containing 3 inflammasome
- DOI
- 10.1097/mca.0000000000001688
- Published
- 2026-11-06
- Container
- Coronary Artery Disease
- Publisher
- Ovid Technologies (Wolters Kluwer Health)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1097/mca.0000000000001688,
title = {Cedrol mitigates atherosclerosis by inhibiting foam cell formation and inflammatory response via suppression of NOD-like receptor family pyrin domain containing 3 inflammasome},
author = {Xiaoyan Cui and Xulu Tian and Xiaoting Li and Xuri Zhang and Jinchan Wu},
year = {2026},
journal = {Coronary Artery Disease},
doi = {10.1097/mca.0000000000001688},
url = {https://doi.org/10.1097/mca.0000000000001688}
}RIS
TY - JOUR TI - Cedrol mitigates atherosclerosis by inhibiting foam cell formation and inflammatory response via suppression of NOD-like receptor family pyrin domain containing 3 inflammasome AU - Xiaoyan Cui AU - Xulu Tian AU - Xiaoting Li AU - Xuri Zhang AU - Jinchan Wu PY - 2026 JO - Coronary Artery Disease DO - 10.1097/mca.0000000000001688 UR - https://doi.org/10.1097/mca.0000000000001688 ER -
APA
Cui, X., Tian, X., Li, X., Zhang, X., & Wu, J. (2026). Cedrol mitigates atherosclerosis by inhibiting foam cell formation and inflammatory response via suppression of NOD-like receptor family pyrin domain containing 3 inflammasome. Coronary Artery Disease. https://doi.org/10.1097/mca.0000000000001688
Source records
- crossref · retrieved 2026-11-08T00:49:32.741Z